A human nuclear shuttling protein that interacts with human immunodeficiency virus type 1 matrix is packaged into virions.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMC 112464)

Published in J Virol on December 01, 2000

Authors

K Gupta1, D Ott, T J Hope, R F Siliciano, J D Boeke

Author Affiliations

1: Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

Articles citing this

Use of a combined ex vivo/in vivo population approach for screening of human genes involved in the human immunodeficiency virus type 1 life cycle for variants influencing disease progression. J Virol (2005) 1.62

Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. J Virol (2002) 1.50

Intracytoplasmic maturation of the human immunodeficiency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin. Retrovirology (2006) 1.39

Tsg101, an inactive homologue of ubiquitin ligase e2, interacts specifically with human immunodeficiency virus type 2 gag polyprotein and results in increased levels of ubiquitinated gag. J Virol (2002) 1.30

An integrative bioinformatic approach for studying escape mutations in human immunodeficiency virus type 1 gag in the Pumwani Sex Worker Cohort. J Virol (2007) 1.10

ATPgammaS disrupts human immunodeficiency virus type 1 virion core integrity. J Virol (2005) 1.08

A hard way to the nucleus. Mol Med (2004) 1.05

Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptation. J Clin Invest (2012) 0.95

Human papillomavirus 16 E6 is associated with the nuclear matrix of esophageal carcinoma cells. World J Gastroenterol (2001) 0.94

Liganded RARalpha and RARgamma interact with but are repressed by TNIP1. Biochem Biophys Res Commun (2009) 0.94

Emerging roles for TNIP1 in regulating post-receptor signaling. Cytokine Growth Factor Rev (2012) 0.93

TNIP1 is a corepressor of agonist-bound PPARs. Arch Biochem Biophys (2011) 0.90

Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study. Ann Rheum Dis (2012) 0.89

Cytoplasmic utilization of human immunodeficiency virus type 1 genomic RNA is not dependent on a nuclear interaction with gag. J Virol (2012) 0.86

PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1. Biochim Biophys Acta (2011) 0.84

TNIP1, a retinoic acid receptor corepressor and A20-binding inhibitor of NF-κB, distributes to both nuclear and cytoplasmic locations. J Histochem Cytochem (2011) 0.83

Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice. J Virol (2001) 0.81

Human immunodeficiency virus type 2 Gag interacts specifically with PRP4, a serine-threonine kinase, and inhibits phosphorylation of splicing factor SF2. J Virol (2004) 0.79

HIV-1 Nef-associated Factor 1 Enhances Viral Production by Interacting with CRM1 to Promote Nuclear Export of Unspliced HIV-1 gag mRNA. J Biol Chem (2016) 0.78

Human TNFα-induced protein 3-interacting protein 1 (TNIP1) promoter activation is regulated by retinoic acid receptors. Gene (2012) 0.77

TNIP1 reduction of HSPA6 gene expression occurs in promoter regions lacking binding sites for known TNIP1-repressed transcription factors. Gene (2014) 0.76

Investigation of the HIV-1 matrix interactome during virus replication. Proteomics Clin Appl (2015) 0.76

Naf1 regulates HIV-1 latency by suppressing viral promoter-driven gene expression in primary CD4+ T cells. J Virol (2016) 0.76

Immune regulator ABIN1 suppresses HIV-1 transcription by negatively regulating the ubiquitination of Tat. Retrovirology (2017) 0.75

Articles cited by this

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01

High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr Genet (1989) 31.80

CRM1 is an export receptor for leucine-rich nuclear export signals. Cell (1997) 18.60

Nuclear targeting sequences--a consensus? Trends Biochem Sci (1991) 16.65

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol (1985) 13.99

A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature (1993) 10.36

The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell (1995) 9.98

Identification of a signal for rapid export of proteins from the nucleus. Cell (1995) 9.92

Identification, developmental regulation, and response to heat shock of two antigenically related forms of a major nuclear envelope protein in Drosophila embryos: application of an improved method for affinity purification of antibodies using polypeptides immobilized on nitrocellulose blots. J Cell Biol (1984) 7.89

The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci U S A (1994) 7.85

Integration of murine leukemia virus DNA depends on mitosis. EMBO J (1993) 7.62

Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science (1997) 6.60

Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol (1994) 6.60

Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc Natl Acad Sci U S A (1993) 6.44

Nuclear protein localization. Biochim Biophys Acta (1991) 6.43

Regulation of the yeast HO gene. Cold Spring Harb Symp Quant Biol (1985) 6.27

In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat Med (1995) 6.26

Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem Biol (1997) 5.49

The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J Virol (1992) 5.30

Protein interaction cloning in yeast: identification of mammalian proteins that react with the leucine zipper of Jun. Proc Natl Acad Sci U S A (1992) 5.28

Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J Virol (1992) 5.19

Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. Proc Natl Acad Sci U S A (1996) 4.70

HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc Natl Acad Sci U S A (1997) 4.59

HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell (1995) 4.41

Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J Virol (1994) 4.28

Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J Virol (1993) 4.20

Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J Virol (1996) 4.08

HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J (1997) 3.99

Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J Virol (1995) 3.95

Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J Virol (1994) 3.85

A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum. J Virol (1993) 3.75

Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit. Cell (1992) 3.73

The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc Natl Acad Sci U S A (1994) 3.65

Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J Exp Med (1989) 3.63

Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J (1998) 3.30

Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virology (1997) 3.24

Cytoplasmic localization of mitogen-activated protein kinase kinase directed by its NH2-terminal, leucine-rich short amino acid sequence, which acts as a nuclear export signal. J Biol Chem (1996) 3.11

Nucleocytoplasmic transport: the last 200 nanometers. Cell (1998) 3.00

Requirement for cell division for initiation of transcription of Rous sarcoma virus RNA. J Virol (1974) 2.86

The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN. J Cell Biol (1999) 2.81

Nuclear export signals and the fast track to the cytoplasm. Cell (1995) 2.77

Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne). J Virol (1988) 2.76

Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. Proc Natl Acad Sci U S A (1998) 2.73

Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J Virol (1996) 2.65

Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle. J Virol (1998) 2.62

Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type I, and other retroviruses. J Virol (1992) 2.36

Use of gelatin/plasma coated flasks for isolating human peripheral blood monocytes. J Immunol Methods (1983) 2.12

Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. J Virol (1999) 2.08

Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain. AIDS Res Hum Retroviruses (1995) 2.01

An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkappaBalpha. EMBO J (1999) 1.88

Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J Virol (1995) 1.77

Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein. J Virol (1996) 1.70

Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J Virol (1996) 1.69

A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature (1999) 1.67

Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology (2000) 1.62

Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection. Cell (1997) 1.40

The majority of cells are superinfected in a cloned cell line that produces high levels of human immunodeficiency virus type 1 strain MN. J Virol (1995) 1.34

Regulation of RelA subcellular localization by a putative nuclear export signal and p50. Mol Cell Biol (1999) 1.32

Identification and cloning of a novel cellular protein Naf1, Nef-associated factor 1, that increases cell surface CD4 expression. FEBS Lett (1999) 1.06

Human immunodeficiency virus type 1 matrix protein interacts with cellular protein HO3. J Virol (1998) 1.04

HEED, the product of the human homolog of the murine eed gene, binds to the matrix protein of HIV-1. J Biol Chem (1999) 1.03

Ultrastructural evidence of an interaction between Env and Gag proteins during assembly of HIV type 1. AIDS Res Hum Retroviruses (1995) 0.99

Cloning and characterization of hIF2, a human homologue of bacterial translation initiation factor 2, and its interaction with HIV-1 matrix. Biochem J (1999) 0.99

Nuclear import and export: transport factors, mechanisms and regulation. Crit Rev Eukaryot Gene Expr (1999) 0.91

A unique amino-terminal sequence predicted for the chicken proto-ets protein. Virology (1988) 0.84

Articles by these authors

(truncated to the top 100)

Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science (1999) 36.25

A positive selection for mutants lacking orotidine-5'-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance. Mol Gen Genet (1984) 35.54

Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast (1998) 23.00

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (1997) 18.10

5-Fluoroorotic acid as a selective agent in yeast molecular genetics. Methods Enzymol (1987) 17.67

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature (1997) 15.49

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med (1999) 12.68

Ty elements transpose through an RNA intermediate. Cell (1985) 9.56

In vitro mutagenesis and plasmid shuffling: from cloned gene to mutant yeast. Methods Enzymol (1991) 8.90

High frequency retrotransposition in cultured mammalian cells. Cell (1996) 8.60

Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell (1996) 8.21

Two genes required for cell fusion during yeast conjugation: evidence for a pheromone-induced surface protein. Mol Cell Biol (1987) 7.38

A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. Proc Natl Acad Sci U S A (2000) 6.49

In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat Med (1995) 6.26

An unusual form of transcriptional silencing in yeast ribosomal DNA. Genes Dev (1997) 6.00

Reverse transcriptase encoded by a human transposable element. Science (1991) 5.86

The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability. Genes Dev (1995) 5.55

Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol (1999) 5.35

Human L1 retrotransposition: cis preference versus trans complementation. Mol Cell Biol (2001) 5.23

Transposable elements and genome organization: a comprehensive survey of retrotransposons revealed by the complete Saccharomyces cerevisiae genome sequence. Genome Res (1998) 5.10

Multiple molecular determinants for retrotransposition in a primer tRNA. Mol Cell Biol (1995) 4.95

Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. Proc Natl Acad Sci U S A (1996) 4.70

A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J (1999) 4.68

The filamentous phage (Ff) as vectors for recombinant DNA--a review. Gene (1983) 4.62

Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine. Science (2002) 4.61

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc Natl Acad Sci U S A (2009) 4.58

Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol (2000) 4.46

Ty element transposition: reverse transcriptase and virus-like particles. Cell (1985) 4.19

A soluble CD4 protein selectively inhibits HIV replication and syncytium formation. Nature (1988) 4.15

Efficient targeted integration at leu1-32 and ura4-294 in Schizosaccharomyces pombe. Genetics (1994) 3.92

The DNA intermediate in yeast Ty1 element transposition copurifies with virus-like particles: cell-free Ty1 transposition. Cell (1988) 3.83

ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr Biol (1998) 3.77

HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy. JAMA (2001) 3.41

An env-like protein encoded by a Drosophila retroelement: evidence that gypsy is an infectious retrovirus. Genes Dev (1994) 2.89

Hotspots for unselected Ty1 transposition events on yeast chromosome III are near tRNA genes and LTR sequences. Cell (1993) 2.89

PRC1: a human mitotic spindle-associated CDK substrate protein required for cytokinesis. Mol Cell (1998) 2.83

A genetic screen for ribosomal DNA silencing defects identifies multiple DNA replication and chromatin-modulating factors. Mol Cell Biol (1999) 2.80

Integration of the yeast retrotransposon Ty1 is targeted to regions upstream of genes transcribed by RNA polymerase III. Genes Dev (1996) 2.74

Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. Proc Natl Acad Sci U S A (1998) 2.73

Saccharomyces cerevisiae SPT3 gene is required for transposition and transpositional recombination of chromosomal Ty elements. Mol Cell Biol (1986) 2.71

Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science (1994) 2.70

Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. Proc Natl Acad Sci U S A (1991) 2.66

Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC. J Immunol (1995) 2.62

Frequent human genomic DNA transduction driven by LINE-1 retrotransposition. Genome Res (2000) 2.60

Targeting of human retrotransposon integration is directed by the specificity of the L1 endonuclease for regions of unusual DNA structure. Biochemistry (1998) 2.59

LINEs and Alus--the polyA connection. Nat Genet (1997) 2.58

Isolation and characterization of the gene encoding yeast debranching enzyme. Cell (1991) 2.57

Chemistry of gene silencing: the mechanism of NAD+-dependent deacetylation reactions. Biochemistry (2001) 2.54

Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature (1985) 2.51

A block to human immunodeficiency virus type 1 assembly in murine cells. J Virol (2000) 2.47

Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol (1998) 2.40

Fine structure of a membrane anchor domain. J Mol Biol (1985) 2.40

Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection. J Infect Dis (2000) 2.25

Minimal Rev-response element for type 1 human immunodeficiency virus. J Virol (1991) 2.22

One and two codon insertion mutants of bacteriophage f1. Mol Gen Genet (1981) 2.20

Distribution of a limited Sir2 protein pool regulates the strength of yeast rDNA silencing and is modulated by Sir4p. Genetics (1998) 2.18

A DNA microarray-based genetic screen for nonhomologous end-joining mutants in Saccharomyces cerevisiae. Science (2001) 2.16

Two related families of retrotransposons from Schizosaccharomyces pombe. Mol Cell Biol (1990) 2.14

High-frequency deletion between homologous sequences during retrotransposition of Ty elements in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1987) 2.12

Viral dynamics in HIV-1 infection. Cell (1998) 2.08

The conserved core of a human SIR2 homologue functions in yeast silencing. Mol Biol Cell (1999) 2.07

Initiator methionine tRNA is essential for Ty1 transposition in yeast. Proc Natl Acad Sci U S A (1992) 2.03

Mammalian Cdc7-Dbf4 protein kinase complex is essential for initiation of DNA replication. EMBO J (1999) 2.01

A specific terminal structure is required for Ty1 transposition. Genes Dev (1990) 2.00

Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1. J Virol (2000) 1.95

Functional organization of the retrotransposon Ty from Saccharomyces cerevisiae: Ty protease is required for transposition. Mol Cell Biol (1988) 1.92

Leptomycin B inhibits equine infectious anemia virus Rev and feline immunodeficiency virus rev function but not the function of the hepatitis B virus posttranscriptional regulatory element. J Virol (1998) 1.90

A rare tRNA-Arg(CCU) that regulates Ty1 element ribosomal frameshifting is essential for Ty1 retrotransposition in Saccharomyces cerevisiae. Genetics (1993) 1.90

An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkappaBalpha. EMBO J (1999) 1.88

The human immunodeficiency virus type 1 gag gene encodes an internal ribosome entry site. J Virol (2001) 1.87

Efficient integration of artificial transposons into plasmid targets in vitro: a useful tool for DNA mapping, sequencing and genetic analysis. Nucleic Acids Res (1994) 1.85

Ty RNA levels determine the spectrum of retrotransposition events that activate gene expression in Saccharomyces cerevisiae. Mol Gen Genet (1990) 1.84

Small open reading frames: beautiful needles in the haystack. Genome Res (1997) 1.83

A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children. J Clin Invest (2000) 1.81

Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein. J Virol (1996) 1.79

Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine. Science (1990) 1.78

A transposon-based strategy for sequencing repetitive DNA in eukaryotic genomes. Genome Res (1997) 1.78

Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J Virol (1995) 1.77

Insertion mutant of bacteriophage f1 sensitive to EcoRI. Proc Natl Acad Sci U S A (1979) 1.76

Retrotransposon R1Bm endonuclease cleaves the target sequence. Proc Natl Acad Sci U S A (1998) 1.75

Yeast retrotransposon revealed. Nature (1992) 1.75

Genetic characterization of a mammalian protein-protein interaction domain by using a yeast reverse two-hybrid system. Proc Natl Acad Sci U S A (1996) 1.72

Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy. Hum Gene Ther (1999) 1.70

The phenomenon of "picky eater": a behavioral marker in eating patterns of toddlers. J Am Coll Nutr (1998) 1.69

Characterization of the nuclear export signal of human T-cell lymphotropic virus type 1 Rex reveals that nuclear export is mediated by position-variable hydrophobic interactions. Mol Cell Biol (1996) 1.69

Posttranscriptional regulation by the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex proteins through a heterologous RNA binding site. J Virol (1992) 1.68

A prokaryotic membrane anchor sequence: carboxyl terminus of bacteriophage f1 gene III protein retains it in the membrane. Proc Natl Acad Sci U S A (1982) 1.64

Host genes that influence transposition in yeast: the abundance of a rare tRNA regulates Ty1 transposition frequency. Proc Natl Acad Sci U S A (1990) 1.64

Effects of bacteriophage f1 gene III protein on the host cell membrane. Mol Gen Genet (1982) 1.62

Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations. EMBO J (1998) 1.62

The Schizosaccharomyces pombe hst4(+) gene is a SIR2 homologue with silencing and centromeric functions. Mol Biol Cell (1999) 1.61

The hepatitis B virus posttranscriptional regulatory element is composed of two subelements. J Virol (1996) 1.61

Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus. J Virol (1994) 1.60

Ty1 transposition in Saccharomyces cerevisiae is nonrandom. Genetics (1989) 1.60

Longitudinal study of nutrient and food intakes of infants aged 2 to 24 months. J Am Diet Assoc (1997) 1.55

Localization of sequences required in cis for yeast Ty1 element transposition near the long terminal repeats: analysis of mini-Ty1 elements. Mol Cell Biol (1990) 1.55

Staphylococcal plasmids that replicate and express erythromycin resistance in both Streptococcus pneumoniae and Escherichia coli. Proc Natl Acad Sci U S A (1982) 1.54

SPT10 and SPT21 are required for transcription of particular histone genes in Saccharomyces cerevisiae. Mol Cell Biol (1994) 1.51

A useful colony colour phenotype associated with the yeast selectable/counter-selectable marker MET15. Yeast (1996) 1.50

Transitions in infant feeding during the first year of life. J Am Coll Nutr (1997) 1.47